3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Carcinoma, Non-Small-Cell Lung
72
Lung Neoplasms
9
Adenocarcinoma of Lung
7
Brain Neoplasms
5
Non-squamous Non-small Cell Lung Cancer
4
NSCLC
4
Adenocarcinoma
4
Mesothelioma, Malignant
3
Colorectal Neoplasms
3
Nonsquamous Non-Small Cell Lung Cancer
2
Non-squamous Cell Non-Small Cell Lung Cancer
2
Neoplasms
2
Meningeal Carcinomatosis
2
Lymphoma
2
Glioma
2
Central Nervous System Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Untreated Advanced Non-Small Cell Lung Cancer
1
Unresectable Stage III NSCLC
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thoracic Neoplasms
1
Stomach Neoplasms
1
Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer
1
Staging IV NSCLC
1
Squamous Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Respiratory Tract Neoplasms
1
Interventions
Thyroidectomy
4
Iodine-131
4
trametinib
3
dabrafenib
3
apatinib
3
anlotinib
2
Surgical Procedures, Operative
2
Blood Specimen Collection
2
Biopsy, Large-Core Needle
2
toripalimab
1
tislelizumab
1
surufatinib
1
regorafenib
1
penpulimab
1
pembrolizumab
1
pazopanib
1
palbociclib
1
olaparib
1
lenvatinib
1
famitinib
1
camrelizumab
1
Ultrasonography
1
Thyroxine
1
Thyrotropin Alfa
1
Sunitinib
1
Second Harmonic Generation Microscopy
1
Routinely Collected Health Data
1
Rosiglitazone
1
Robotic Surgical Procedures
1
Radiotherapy, Intensity-Modulated
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Thyroid Neoplasms
×
Pemetrexed
×
Clear all
NCT00786552
2011-01-20
Panthera
University Hospital Schleswig-Holstein
Phase 2
Unknown
47 enrolled